Do Microplastics Cause Heart Attacks? What the Studies Actually Show

Researchers have detected micro- and nanoplastics in coronary blood, arterial plaque, and blood clots. Several human studies report associations with cardiovascular disease or later events. That pattern is concerning and worth investigating, but current evidence does not show that plastic particles caused any individual heart attack or that reducing kitchen plastic contact prevents one.

Quick answer

No study has yet proved that microplastics cause heart attacks. The strongest current evidence consists of human detection and observational studies. A small 2026 study found plastics more often and at higher levels in coronary blood from patients having a serious heart attack. A 2024 study linked particles in carotid plaque with more heart attacks, strokes, or deaths during follow-up. Both findings can support an association, not cause and effect.

Three things to know

• Researchers are finding a repeatable signal: Plastic particles or polymer signatures have been reported in blood, plaque, and clots across several cardiovascular studies.
• The studies have important limits: Small or selected patient groups, emerging measurement methods, confounding, and uncertainty about timing prevent causal conclusions.
• Established heart care still comes first: Exposure-reduction choices may be reasonable, but they are not substitutes for proven prevention, diagnosis, or treatment.

How the main claims hold up

Claim 1: Were plastics found more often in patients having a heart attack?

PFK verdict: Supported in one small patient sample, not established as a universal pattern.

In a 2026 European Heart Journal study, researchers analyzed coronary and peripheral blood from 61 people undergoing coronary angiography. Micro- and nanoplastics were detected in 84.2% of 19 patients experiencing an ST-elevation myocardial infarction, or STEMI, compared with 40% of 20 patients with chronic coronary disease and 31.8% of 22 controls whose coronary arteries appeared normal.

The STEMI group also had higher measured concentrations and more polymer types. Among heart-attack patients, concentrations were highest near the blocked artery. These findings describe this group at one clinical encounter. They do not show whether particles were present before the event, increased because of the event, or were affected by emergency care.

Claim 2: Do detected microplastics predict later cardiovascular events?

PFK verdict: A notable observational study found an association, but detection is not a validated personal risk test.

A 2024 New England Journal of Medicine study examined carotid-artery plaque from 304 surgical patients. Polyethylene was detected in 58.4% of plaques. Among 257 patients who completed nearly three years of average follow-up, those with detected micro- or nanoplastics had a higher rate of heart attack, stroke, or death.

This is an important human signal because tissue measurements came before the later outcomes. Still, the participants already had carotid disease severe enough to require surgery. Differences in health, behavior, environment, or treatment could have influenced both detection and outcomes.

Claim 3: Do other cardiovascular studies point in the same direction?

PFK verdict: Yes, several studies report related detection and association findings, but the methods and patient groups differ.

A separate 2024 Journal of Hazardous Materials study analyzed arterial tissue from 17 selected surgical patients: four coronary plaque specimens, seven carotid plaque specimens, and six plaque-free ascending-aortic specimens from patients with aortic dissection. Using Py-GC/MS, researchers reported targeted polymer-mass detections in all 17, averaging 118.66 micrograms per gram of tissue. Levels were higher in the plaque-bearing groups than in the aortic group.

This shows occurrence in those specimens, not population prevalence. The aortic specimens were not matched healthy controls. Vessel, tissue layer, disease, and procedure differed across groups. The destructive method measured polymer mass but did not establish intact-particle count, size, shape, or location. The study cannot show whether plastic material preceded plaque, accumulated because of plaque, or contributed to it.

A 2024 study of 101 patients with chest pain reported higher blood microplastic concentrations across groups with normal arteries, unstable angina, and acute myocardial infarction. Another found microplastics in clots removed from 24 of 30 patients treated for stroke, heart attack, or deep-vein thrombosis, but had no comparable group without clots. A 2025 study linked coronary-blood polymer measurements and inflammatory markers with later major cardiovascular events after myocardial infarction.

Together, these papers justify larger, independent research. They do not turn several observational signals into proof of causation.

Claim 4: Is there a plausible way particles could affect the heart?

PFK verdict: Plausible mechanisms exist, but they have not been shown to explain heart attacks in people.

The 2026 study reported higher inflammatory markers alongside plastic detection. Laboratory research also identifies possible pathways involving inflammation and oxidative stress. A plausible mechanism can strengthen a hypothesis, but it cannot establish that the same pathway caused a clinical event. Smoking, air pollution, existing disease, and other exposures remain difficult to separate. In the 2026 analysis, smoking was the only independent predictor of plastic detection after adjustment.

What PFK recommends now

Keep established heart-health priorities in perspective: avoid smoking, manage blood pressure and LDL cholesterol with a clinician, stay active, and seek immediate care for possible heart-attack symptoms.

If you also want to reduce avoidable plastic contact, focus on manageable, high-contact situations:

• Move food to glass or ceramic before microwaving when practical.
• Use glass or stainless steel for hot drinks and frequently used storage.
• Check plastic contact across kettles, coffee makers, pods, infusers, and lids.
• Replace heavily worn plastic cutting boards or utensils with suitable alternatives.

These choices may reduce some contact. Research has not quantified how much they change total exposure, and no kitchen product has been shown to prevent cardiovascular disease.

PFK assessment: The cardiovascular evidence is serious enough to investigate, but not strong enough to call microplastics a confirmed cause, a personal risk score, or a reason to displace proven heart care.

How PFK evaluated these claims

We applied the same five tests to every claim rather than treating detection, association, mechanism, and clinical benefit as interchangeable.

• Endpoint: Did the study measure particles, polymer mass, inflammation, or an actual cardiovascular event?
• Design: Was it a snapshot, follow-up cohort, laboratory experiment, or intervention?
• Timing: Could researchers show that the measured particles preceded the disease or event?
• Alternatives: Were smoking, air pollution, underlying disease, medical care, and other factors addressed?
• Reproducibility: Were methods standardized, contamination-controlled, and independently repeated in larger groups?

Across all claims, the evidence supports detection and concerning associations. It does not yet establish causation, a clinically useful risk threshold, or a cardiovascular benefit from reducing exposure.

Research reviewed August 2, 2026. This article is for educational purposes and is not medical advice. Seek urgent medical care for possible heart-attack symptoms.

Sources

1. Paolisso P, et al. “Micro- and nano-plastics in the coronary circulation and air pollution exposure in ischaemic heart disease presentation.” European Heart Journal. Published online July 14, 2026. DOI: 10.1093/eurheartj/ehag447.
2. Marfella R, et al. “Microplastics and Nanoplastics in Atheromas and Cardiovascular Events.” New England Journal of Medicine. 2024. DOI: 10.1056/NEJMoa2309822.
3. Liu S, et al. “Microplastics in three types of human arteries detected by pyrolysis-gas chromatography/mass spectrometry (Py-GC/MS).” Journal of Hazardous Materials. 2024;469:133855. DOI: 10.1016/j.jhazmat.2024.133855.
4. Yang Y, et al. “Multimodal detection and analysis of microplastics in human thrombi from multiple anatomically distinct sites.” EBioMedicine. 2024. DOI: 10.1016/j.ebiom.2024.105118.
5. Wang J, et al. “Microplastics are associated with elevated atherosclerotic risk and increased vascular complexity in acute coronary syndrome patients.” Particle and Fibre Toxicology. 2024. DOI: 10.1186/s12989-024-00596-4.
6. “Microplastics and nanoplastics increase major adverse cardiac events in patients with myocardial infarction.” Journal of Hazardous Materials. 2025. DOI: 10.1016/j.jhazmat.2025.137624.
7. Greenwood V. “The Emerging Link Between Microplastics and Heart Disease.” TIME. July 16, 2026. Read the article.
8. Science Media Centre. “Expert reaction to micro- and nano-plastics in the coronary circulation and air pollution exposure in ischaemic heart disease presentation.” July 2026. Read the expert commentary.